Covid-Intervention-Study

Psychosocial Intervention Clinical Trial

— CIS  

Official title:

Manual-based Psychosocial Group Interventions for Coping With the Covid-19 Pandemic and Other Crises

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05597501
• Other study ID #: 21/2021-2024
• Status: Recruiting
• Phase: N/A
• Start date: November 2022
• Est. completion date: November 2024

Study information

• Verified date: October 2022
• Source: Department for Psychosomatic Medicine and Psychotherapy, University for Continuing Education Krems
• Contact: Carina Dinhof, MSc.
• Phone: +43 2732 893
• Email: cis[@]donau-uni.ac.at
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this invention study is test and compare short-term manual-based psychosocial group interventions in die Austrian population suffering from stresses and strains due to the Covid-19 Pandemic and other crises. The main question it aims to answer: Does short-term manual-based psychosocial group interventions improve the mental well-being of the participants? Participants will attend weekly a manual-based group (8 weeks) and answer online-questionnaires and surveys (pseudonymized).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 96
• Est. completion date: November 2024
• Est. primary completion date: December 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• above 18 years with psychosocial stresses and strains due to covid-19 pandemic and other crises

Exclusion Criteria:

• suicidal tendency
• insufficient knowledge of the German language
• psychotic episode
• no internet-access

Related Conditions & MeSH terms

• Psychosocial Intervention

Intervention

Behavioral:
• manual-based group interventions
weekly group interventions (90min) following manuals of either CBT, integrative therapy or existential analysis&logotherapy

Locations

Country	Name	City	State
Austria	University of Continuing Education Krems	Krems an der Donau

Sponsors (1)

Lead Sponsor	Collaborator
Department for Psychosomatic Medicine and Psychotherapy, University for Continuing Education Krems

Country where clinical trial is conducted

Austria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Positive Mental Health Scale (PMH)		Screening - Start Intervention - after 8 weeks intervention - 4 months follow-up
Secondary	WHO-Five Well-Being Index (WHO-5)		Screening - Start Intervention - after 8 weeks intervention - 4 months follow-up
Secondary	Patient Health Questionnaire-9 (PHQ-9)		Screening - Start Intervention - after 8 weeks intervention - 4 months follow-up
Secondary	Generalized Anxiety Disorder Scale-7 (GAD-7)		Screening - Start Intervention - after 8 weeks intervention - 4 months follow-up
Secondary	Somatic Symptome Scale-8 (SSS-8)		Screening - Start Intervention - after 8 weeks intervention - 4 months follow-up
Secondary	Stress Coping Inventars (SCI)		Screening - Start Intervention - after 8 weeks intervention - 4 months follow-up
Secondary	Pereived Stress Scale (PSS)		Screening - Start Intervention - after 8 weeks intervention - 4 months follow-up